Steed H, Capstick V, Schepansky A, Honore L, Hiltz M, Faught W
Department Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Alberta, Edmonton, AB, Canada.
Gynecol Oncol. 2006 Oct;103(1):53-7. doi: 10.1016/j.ygyno.2006.01.027. Epub 2006 Mar 3.
To determine the incidence of parametrial involvement in clinical stage IA and IB1 cervical cancer and whether pelvic lymph node status is a predictor of parametrial status.
Retrospective review of 120 patients with FIGO stage IA/IB1 cervical carcinoma treated by class II radical abdominal hysterectomy between January 1997 and December 2001 was performed. The parametria were examined for microscopic involvement of parametrial lymph nodes and/or tissue. Continuous variables were compared using Wilcoxon rank sum test, and Fisher's exact test was used to categorical variables. Kaplan-Meier curves were constructed for overall survival (OS) and recurrence-free survival (RFS). Cox proportional hazards model was used to investigate prognostic factors.
One hundred ten patients were eligible. Five patients (5%) had positive parametria and 13 patients (12%) had positive pelvic lymph nodes. Four (80%) patients with positive parametria had positive pelvic lymph nodes. The groups did not differ significantly in terms of age (P = 0.92), histology (P = 0.15), or LVSI (P = 0.20). Positive parametria was associated with larger tumor size (3.0 vs. 2.0 cm, P < 0.05), greater depth of invasion (16 mm vs. 5 mm, P = 0.03), and pelvic lymph node metastases (80% vs. 10%, P = 0.001). The only variable that was significant in the proportional hazards model was lymph node status (P = 0.02). After median follow-up of 48 months, there was a significant difference in recurrence (40% vs. 4%, P = 0.03) and RFS (0.0003).
Acknowledging small sample size and retrospective study, positive parametrial involvement in stage IA and IB1 cervical cancer is infrequent. There is a significant association with lymph node status. Thus, there may be a role for less radical surgery combined with pelvic lymphadenectomy in this patient population.
确定临床IA期和IB1期宫颈癌宫旁组织受累的发生率,以及盆腔淋巴结状态是否为宫旁组织状态的预测指标。
对1997年1月至2001年12月期间接受II类根治性腹式子宫切除术治疗的120例FIGO IA/IB1期宫颈癌患者进行回顾性研究。检查宫旁组织有无宫旁淋巴结和/或组织的微小浸润。连续变量采用Wilcoxon秩和检验进行比较,分类变量采用Fisher精确检验。构建总生存(OS)和无复发生存(RFS)的Kaplan-Meier曲线。采用Cox比例风险模型研究预后因素。
110例患者符合条件。5例(5%)宫旁组织阳性,13例(12%)盆腔淋巴结阳性。4例(80%)宫旁组织阳性患者盆腔淋巴结阳性。两组在年龄(P = 0.92)、组织学(P = 0.15)或脉管间隙浸润(LVSI,P = 0.20)方面无显著差异。宫旁组织阳性与肿瘤较大(3.0 vs. 2.0 cm,P < 0.05)、浸润深度更深(16 mm vs. 5 mm,P = 0.03)及盆腔淋巴结转移(80% vs. 10%,P = 0.001)相关。比例风险模型中唯一显著的变量是淋巴结状态(P = 0.02)。中位随访48个月后,复发(40% vs. 4%,P = 0.03)和无复发生存(P = 0.0003)存在显著差异。
鉴于样本量小及为回顾性研究,IA期和IB1期宫颈癌宫旁组织阳性受累情况不常见。与淋巴结状态存在显著关联。因此,对于该患者群体,可能可采用根治性较小的手术联合盆腔淋巴结清扫术。